AR015812A1 - Proceso para producir una formulacion farmaceutica en pastillas - Google Patents

Proceso para producir una formulacion farmaceutica en pastillas

Info

Publication number
AR015812A1
AR015812A1 ARP980102364A ARP980102364A AR015812A1 AR 015812 A1 AR015812 A1 AR 015812A1 AR P980102364 A ARP980102364 A AR P980102364A AR P980102364 A ARP980102364 A AR P980102364A AR 015812 A1 AR015812 A1 AR 015812A1
Authority
AR
Argentina
Prior art keywords
pills
produce
pharmaceutical formulation
flurbiprofen
forming composition
Prior art date
Application number
ARP980102364A
Other languages
English (en)
Spanish (es)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of AR015812A1 publication Critical patent/AR015812A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980102364A 1997-05-22 1998-05-21 Proceso para producir una formulacion farmaceutica en pastillas AR015812A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process

Publications (1)

Publication Number Publication Date
AR015812A1 true AR015812A1 (es) 2001-05-30

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102364A AR015812A1 (es) 1997-05-22 1998-05-21 Proceso para producir una formulacion farmaceutica en pastillas

Country Status (31)

Country Link
US (1) US6194003B1 (https=)
EP (1) EP0983059B1 (https=)
JP (1) JP2001527567A (https=)
KR (1) KR20010012739A (https=)
CN (1) CN1154480C (https=)
AR (1) AR015812A1 (https=)
AT (1) ATE245021T1 (https=)
AU (1) AU725760B2 (https=)
BG (1) BG103881A (https=)
BR (1) BR9809651A (https=)
CA (1) CA2290830C (https=)
CZ (1) CZ290816B6 (https=)
DE (1) DE69816440T2 (https=)
DK (1) DK0983059T3 (https=)
ES (1) ES2202871T3 (https=)
GB (1) GB9710521D0 (https=)
HU (1) HU224954B1 (https=)
ID (1) ID22949A (https=)
IL (1) IL132999A0 (https=)
IN (1) IN187837B (https=)
MY (1) MY118410A (https=)
NO (1) NO995681L (https=)
NZ (1) NZ500664A (https=)
PL (1) PL190947B1 (https=)
PT (1) PT983059E (https=)
RU (1) RU2203046C2 (https=)
SK (1) SK283701B6 (https=)
TR (1) TR199902725T2 (https=)
UA (1) UA53714C2 (https=)
WO (1) WO1998052539A1 (https=)
ZA (1) ZA984260B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1235558T3 (da) 1999-12-09 2006-10-09 Reckitt Benckiser Healthcare Sammenpresset tabletsammensætning, der omfatter et NSAID
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
WO2009014960A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
AU2009284011B2 (en) * 2008-08-22 2013-12-12 Reckitt Benckiser Healthcare (Uk) Limited Sore throat compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
SMT202100228T1 (it) 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
RU2203046C2 (ru) 2003-04-27
BR9809651A (pt) 2000-07-11
JP2001527567A (ja) 2001-12-25
WO1998052539A1 (en) 1998-11-26
US6194003B1 (en) 2001-02-27
CN1255848A (zh) 2000-06-07
MY118410A (en) 2004-10-30
NO995681D0 (no) 1999-11-19
SK283701B6 (sk) 2003-12-02
HUP0002121A3 (en) 2001-04-28
EP0983059A1 (en) 2000-03-08
CA2290830C (en) 2006-07-11
AU725760B2 (en) 2000-10-19
GB9710521D0 (en) 1997-07-16
IN187837B (https=) 2002-06-29
PL190947B1 (pl) 2006-02-28
ES2202871T3 (es) 2004-04-01
AU7916598A (en) 1998-12-11
EP0983059B1 (en) 2003-07-16
CZ290816B6 (cs) 2002-10-16
DE69816440T2 (de) 2004-05-13
SK158899A3 (en) 2000-05-16
TR199902725T2 (xx) 2000-02-21
ZA984260B (en) 1999-02-20
CN1154480C (zh) 2004-06-23
PT983059E (pt) 2003-11-28
CA2290830A1 (en) 1998-11-26
NZ500664A (en) 2001-01-26
IL132999A0 (en) 2001-03-19
DK0983059T3 (da) 2003-11-03
UA53714C2 (uk) 2003-02-17
DE69816440D1 (de) 2003-08-21
KR20010012739A (ko) 2001-02-26
ATE245021T1 (de) 2003-08-15
HU224954B1 (en) 2006-04-28
PL336624A1 (en) 2000-07-03
CZ412099A3 (cs) 2000-02-16
NO995681L (no) 1999-11-19
HUP0002121A2 (hu) 2000-12-28
ID22949A (id) 1999-12-16
BG103881A (bg) 2000-05-31

Similar Documents

Publication Publication Date Title
AR015812A1 (es) Proceso para producir una formulacion farmaceutica en pastillas
PT101175A (pt) Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos
ES2081349T3 (es) Rotogranulaciones y recubrimientos para enmascarar el sabor para la preparacion de comprimidos farmaceuticos de mascar.
HUP9603530A3 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
DE3683385D1 (de) Einrichtungen fuer die kontrollierte abgabe von aktiven substanzen und verfahren zu ihrer herstellung.
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
UA26449C2 (uk) Тверда лікарська форма для оральhого застосуваhhя з сповільhеhим вивільhеhhям активhої речовиhи і спосіб її виготовлеhhя (варіаhти)
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
BR9800871A (pt) Processo para a preparação de formas medicamentosas combinadas sólidas, e, forma medicamentosa combinada sólida.
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
ES2136612T3 (es) Composiciones de sorbitol/xilitol cocristalizado en masa fundida.
HUT44441A (en) Process for preparing antineoplastic pharmaceutical composition
CA2393585A1 (en) Therapeutic agents
RU99126868A (ru) Способ изготовления таблеток флурбипрофена
PT85158A (en) Process for preparing novel pharmaceutical compositions for topical application with systemic action containing diclofenac
DK658387D0 (da) Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf
AR005353A1 (es) Formulacion de hormona para crecimiento animal de liberacion sostenida, y un procedimiento para la preparacion de la misma
ES509179A0 (es) &#34;un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen&#34;.
BR9909637A (pt) Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos
ATE112163T1 (de) Verfahren zur herstellung einer festem pharmazeutischen zusammensetzung.
JPS57130913A (en) Direct compress analgesic drug granulating composition, tablets thereof and manufacture
PT84526B (pt) Processo para a preparacao de uma composicao solida compreendendo granulos consistindo essencialmente de um agregado de cristais de ibuprofeno
DZ1937A1 (fr) Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procédé pour les préparer.
AU7292794A (en) A method of manufacturing a laxative composition dosage unit and dosage units obtained thereby

Legal Events

Date Code Title Description
FA Abandonment or withdrawal